The New York Times: Danish Cannabis IPO Aims to Benefit From Surge in Investor Interest
Reuters, 21 September 2018
“Danish cannabis firm StenoCare is preparing to list shares in Copenhagen next month, the first in Europe to launch an initial public offering (IPO) to take advantage of a surge in investor interest.”
“Scientists say evidence is growing that cannabis can ease epilepsy and other conditions – such as chronic pain, multiple sclerosis and chemotherapy-induced nausea – prompting renewed interest in the field.
Denmark is one of several European countries, which also include Germany, Britain, the Czech Republic and Italy, that have allowed the prescription of medicinal cannabis oil.
Denmark, which legalised the medicinal use of cannabis from Jan. 1 this year, is also one of the few European nations to legalise its local production as well.”